Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
pharmaphorum
5h
Gilead, MSD say HIV combo could be weekly, oral HIV drug
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
FierceBiotech
6h
Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program
Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...
The Pharma Letter
15h
Gilead and Merck tout first weekly oral HIV treatment
US drugmakers Gilead Sciences (Nasdaq: GILD) and Merck & Co (NYSE: MRK) have announced new results from a Phase II clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
The Vessel to reopen
Helicopter hits radio tower
Oscar makes landfall
Faces new lawsuits
Gold hits fresh high
Albany State shooting
WWII code talker dies
American activist Wair dies
NYC subway death trial
New Mexico flash flooding
Hezbollah assets targeted
Anti-missile system in Israel
Wins third PGA Tour title
To roll out AI agents in Nov
Ceasefire talks in Beirut
Advance to World Series
Opens up on Russian camp
Blinken's Middle East trip
Oakland fire burns homes
Launches OneWeb mission
Baldwin returns to 'SNL'
Urges support for Ukraine
Rock & Roll HOF '24 class
CVS workers strike
Orionids meteor shower
Ferry dock collapses in GA
US probing documents leak
Postpones US tour
Related topics
lenacapavir
Gilead Sciences
Feedback